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controls the division and differentiation of
hematopoietic cells
Miguel Chaves-Ferreira1,3, Gerald Krenn1, Florence Vasseur1,2, Aleksandr Barinov1,2, Pedro Gonçalves1, Orly Azogui1,
Ana Cumano2, Zhi Li2, Sandra Pellegrini2, Benedita Rocha1,2* and Diego Laderach1,4*Abstract
Background: The family of D cyclins has a fundamental role in cell cycle progression, but its members (D1, D2, D3)
are believed to have redundant functions. However, there is some evidence that contradicts the notion of mutual
redundancy and therefore this concept is still a matter of debate.
Results: Our data show that the cyclin D1 is indispensable for normal hematopoiesis. Indeed, in the absence of D1,
either in genetic deficient mice, or after acute ablation by RNA interference, cyclins D2 and D3 are also not
expressed preventing hematopoietic cell division and differentiation at its earliest stage. This role does not depend
on the cyclin box, but on the carboxyl regulatory domain of D1 coded by exons 4–5, since hematopoietic
differentiation is also blocked by the conditional ablation of this region.
Conclusion: These results demonstrate that not all functions of individual D cyclins are redundant and highlight a
master role of cyclin D1 in hematopoiesis.
Keywords: D cyclins, Hematopoiesis, Cell cycleBackground
In mammalian cells, D type cyclins have a fundamental
role in the initiation of the cell division in response to
environmental signals. After exogenous stimulation, they
are rapidly up regulated and form active holoenzyme
complexes with their catalytic partners, the cyclin
dependent kinases (CDK) 4/6. These complexes migrate
to the nucleus in early-G1, where they monophosphory-
late the retinoblastoma protein (Rb) [1]. Cyclins D/
CDK4/6 activity is only required for transition through
early G1 phase and across the restriction point into late
G1 phase [1]. Progression through the late G1 phase and
the G1/S transition are mediated by cyclin E/CDK2
complexes that phosphorylate Rb in other sites. Rb* Correspondence: benedita.rocha@inserm.fr; diegoladerach@qb.fcen.uba.ar
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transcription factor family members, allowing the tran-
scription of several genes fundamental for cell cycle pro-
gression [Reviewed in [2]].
The cyclin D family comprises three members (D1,
D2, D3), which have different tissue distribution. The
role of each individual member of this family is yet sub-
ject of debate. Studies of mice deficient in individual cyc-
lin D family members proposed that all D cyclins would
have redundant functions. The role of each D cyclin in
each tissue would therefore depend only of its expres-
sion in that tissue, a block of mouse development and
hematopoiesis requiring the combined deficiency of all
three D type cyclins [3].
Other evidence contradicts the notion of mutual re-
dundancy. The D cyclins share a homologous cyclin box,
but also have non-homologous domains. Numerous re-
ports described that the cyclin D1 has major roles in the
regulation of gene expression, not shared by other D
cyclins. Such roles do not depend on the conserved cyc-
lin box, but rather in the non-homologous carboxyl andis article is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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tory domains [4–7]. The D1 regulatory functions include
the control of promoter accessibility [4, 6, 8, 9], the pro-
motion of genome instability [7] and/or the contribution
to DNA repair [10]. By genome-wide Chip analysis, D1
was found to bind up to 2840 putative sites of both
proximal and distal promoters [7]. In particular, D1
bound the promoters of abundantly expressed genes,
and controlled the expression of several important tran-
scription factors involved in cell differentiation, includ-
ing Notch1 [9] and NF-kB [11]. Of note, D1 binds to the
promoters of cyclin D2 (Ccnd2) and cyclin D3 (Ccnd3)
[9] suggesting that it could also be involved in their tran-
scription, therefore having a major impact in initiating
cell cycle progression. Results obtained in mice deficient
in cyclin D3 further support that the functions of the in-
dividual members of the D cyclin family are not fully re-
dundant. Since these mice express both D1 and D2, fully
redundant functions of all D cyclins would be incompat-
ible with the role of D3 in TN3-TN4 transition and in B
cell differentiation [12, 13]. Besides, while the D1 defi-
cient colony shows a very high mortality rate [14], col-
onies of D2 and D3 deficient mice do not [12, 15].
These observations suggest that each of the three D-
cyclins may play unique, non-exchangeable cellular and
tissular functions.
To address these controversies we studied mice previ-
ously described as D1 deficient, eliminated the expres-
sion of D1 by RNAi, overexpressed 4–5 in WT LSKs
and generated conditional deficient mice which lack the
D1 regulatory domains coded by exons 4–5. We here
show that D1 regulates the expression of the mRNAs
coding for D2 and D3, the absence of D1 preventing the
division and differentiation of hematopoietic lineage
cells. Overall, the data demonstrate a fundamental role
of D1 in hematopoiesis, mediated by the carboxyl regu-
latory domain coded by exons 4–5.
Results
The hematopoietic differentiation in “D1 deficient” mice
The mice previously described as D1 deficient [14]
(hereafter referred to as Ccnd1Δ1-3 mice) were produced
by the insertion of a Neomycin cassette leading to the
deletion of Ccnd1 exons 1–3 (encoding the D1 N-
terminal regulatory domain and the cyclin box) but spar-
ing the Ccnd1 promoter, the 5′ un-translated region,
and the exons 4 and 5, these latter coding one of the D1
regulatory domains. This colony is known to have a high
mortality rate [14]. To ensure Ccnd1Δ1–3 mice survival
we had to develop unique breeding conditions (de-
scribed in methods), since in standard breeding condi-
tions we mainly obtained wild type (WT) or
heterozygous mice. However, in spite of these condi-
tions, in 684 mice born from crosses betweenheterozygous Ccnd11–3−/+ mice the frequency of viable
Ccnd1Δ1–3 mice (15 %) was lower than the 25 % pre-
dicted by Mendel laws, indicating prenatal mortality. A
substantial fraction of homozygous mice also died in the
first two-three weeks after birth.
Therefore, we first studied 4-weeks-old mice. In these
mice, hematopoietic differentiation was very heteroge-
neous. Thymocyte numbers ranged from less than
0.5×106 cells, to over 500x106 cells. Based on the thymus
size we subdivided this colony into four Groups (Fig. 1a).
Group I mice had a severe thymus atrophy. The thymi
had very few CD4+CD8+ (double positive-DP) cells
(Fig. 1b, upper graphs). The distribution of triple-
negative (TN: CD4−CD8−CD3− Lineage− thymocytes)
subpopulations was abnormal. In contrast to WT mice,
where the more mature CD44−CD25+ (TN3) and CD44−
CD25− (TN4) populations are prevalent [16], TN3 and
TN4 thymocytes were virtually absent (Fig. 1b, middle
graphs). Either the TN compartment was mostly consti-
tuted of CD44+CD25− (TN1) and CD44+CD25+ (TN2)
populations (Fig. 1b), or only had TN1 thymocytes (not
shown). Since the TN1 thymocytes harbor different sub-
populations, we further quantified the early thymocyte
progenitors (ETP), believed to be the progenitors of all
thymocyte sets and characterized by the co-expression
of CD24 and c-kit (CD117) [16]. We found that in
Group I mice ETPs were reduced up to 50 fold when
compared to WT mice (Fig. 1b, lower graphs). There-
fore, the Ccnd11-3 deficiency may block thymus differen-
tiation at its earliest stage. The major reduction of the
ETPs further suggests that differentiation blocks may
precede thymus seeding, i.e., may already be present in
progenitors located in the bone marrow (BM).
Group II mice had moderate thymus atrophy. The
thymocyte populations were enriched in TN cells and
had fewer DP cells. The block on TN differentiation oc-
curred at a later stage, i.e., in the TN3 to TN4 transition.
Analysis of the TN1 population, however, showed a re-
duction of the ETP compartment, although less import-
ant than that found in Group I mice (Fig. 1b). Finally, in
Group III (Fig. 1b) and Group IV (not shown) the
thymocyte sub-populations distribution appeared similar
to that of WT mice. However, the analysis of the TN1
compartment showed that these mice were also abnor-
mal. In contrast to previous Groups where ETP popula-
tions were reduced, these mice had more ETPs than
their WT littermates (Fig. 1b, lower graphs).
B cell differentiation in the BM progresses from pre-
pro B (B220low CD43+ CD24−) to pro B (B220low CD43+
CD24+) to pre-B (B220low CD43−) to naïve B cells
(B220high IgM+) [17]. In Ccnd1Δ1-3 mice, B cell lineage
differentiation blocks paralleled those found in the thymus
(Fig. 2). Group I mice had a major pre-pro B differenti-
ation block. Most B lineage cells were B220low CD43+
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Fig. 1 The thymocytes from 4 weeks old Ccnd1Δ1-3 mice. a Thymocyte yields from different Groups of Ccnd1Δ1-3 mice. The number of mice in
each Group is shown in brackets: GrI (11), GrII (12), GrIII (25) and GrIV (10); results are expressed as the mean +/− SE. b The distribution of
thymocyte populations. Dot plots are from a representative experiment in which 4-weeks-old littermates belonging to different Groups were
studied simultaneously. Group IV is not shown, since 4-weeks-old mice do not have this Group. c Bar graphs represent the mean+/− SE from all
mice we studied. The number of mice in each Group is shown in brackets: GrI (15) GrII (12) GrIII (26). Upper graphs: CD4/CD8 profiles in CD19
−TER119−Gr-1− thymocytes. Middle graphs: CD44/CD25 profiles in triple negative (TN: CD3−CD8−CD4−CD19−TER119−Gr-1−) cells. Lower graphs:
CD44+ CD25− TN1 populations, subdivided by their expression of CD24 and CD117. Numbers show the yields of ETPs (CD24+ CD117+)/thymus.
Statistic significance: *p < 0.05; **p < 0.005; ***p < 0.001
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tial pre-proB block and a reduction in pre-B cells, while in
Groups III, IV B cell differentiation appeared normal
(Fig. 2a). Earlier lymphoid lineage precursors were also af-
fected. Group I mice had rare Lineage−IL-7R+Sca-1+CD117+
common lymphocyte progenitors (CLPs), and in the
Group II mice the number of CLPs was also reduced,
albeit to lesser extent. In contrast LSKs (Lineage−
Sca-1+CD117+) and myeloid and erythroid lineages
were not affected. Surprisingly, further anal- ysis of these
precursors revealed that Group III was also abnormal.
The number of CLP and LSK were actually increased as
compared to WT littermates (Fig. 2b).
The high mortality in the Ccnd1Δ1-3 colony associates with
a deficiency of hematopoietic precursors and a high
expression of D1 during the fetal and perinatal period
To identify the reasons justifying the high prenatal and
perinatal mortality in this colony we studied 9-days-old
mice. At this age the majority of Ccnd1Δ1-3 mice had a
Group I phenotype. Moreover, besides the modifications
described above in 4-weeks-old Group I mice, 9-days-
old Ccnd1Δ1-3 mice also had an additional severe deple-
tion of LSKs and erythroid and myeloid lineage cells
(Fig. 2c). These results demonstrate that the Ccnd11-3
deficiency already affects LSK generation. The deficiency
in LSKs, erythroid and myeloid lineage cells is sufficient
to explain the death of homozygous mice, since either
lineage is required for survival. These results do not ex-
clude additional roles of D1 in other organs, which may
contribute the high mortality rate in this colony.
These results raise several questions: (i) Why has the
Ccnd11-3 deletion a higher effect during the embryonic
and perinatal period?; (ii) How can a single deletion as-
sociate with three very different phenotypes?; (iii) How
does the deletion of a single member of the cyclin D
family affect hematopoietic differentiation, since other D
cyclins, (that should guarantee cell division/differenti-
ation), are still present?; (iii) How do some mice survive
the effects of the Ccnd11–3 deletion, i.e., what are the
“compensatory mechanisms” involved?
To address the first question we studied if the major
effect of the Ccnd11-3 deficiency during the pre-natal
and perinatal periods was due to different expressionlevels of Ccdn1. We first quantified Ccdn1 in compari-
son with the more abundant Ccnd2 in hematopoietic
cells obtained from 9-days-old and 4-weeks-old WT
mice. As both PCR amplifications have the same effi-
ciency, the expression levels of both cyclins can be dir-
ectly compared. Interestingly, although Ccnd1 was
expressed in all hematopoietic lineage cells, there were
major differences in the expression levels with age;
Ccnd1 was expressed at higher levels in immature pre-
cursors during the neonatal period (Fig. 3a). Its relative
expression in hematopoietic progenitors declined with
age. We next studied Ccnd1 expression in different
hematopoietic precursors (LSKs, TN1 and CD19+CD43+
B cell precursors) of 15-days-old WT embryos, the earli-
est time point when all these precursors can be identi-
fied. We found that Ccnd1 was also highly expressed in
these precursors, when compared to adult mice. The
relatively high expressions of Ccnd1 during the fetal and
perinatal periods explain the major impact of the
Ccnd11-3 deficiency during these ages (Fig. 3b).
The age-related differences of the relative expression
of D1, as well as the evolution of Ccnd1Δ1-3 mice pheno-
types with age, explained how modifications in a single
genetic allele give rise to mice with several phenotypes.
In 9-days-old mice, hematopoietic multi-potent precur-
sors express high levels of D1. Therefore, LSKs and all
hematopoietic lineage cells are affected by this deletion,
as found in 9-days-old Group I mice. In surviving mice,
LSKs undergo a “compensatory” mechanism, since LSKs
numbers are no longer reduced in 4-weeks-old Group I
mice. Moreover, these “compensated” LSKs are compe-
tent as shown by their ability to generate both myeloid
and erythroid lineage cells, present at normal levels in 4-
weeks-old mice. Once competent LSKs are generated,
these cells will differentiate progressively into all
hematopoietic lineages, but this differentiation is known
to take time. Therefore, the more immature cell sets will
be generated first, explaining the phenotype of Group II
mice, which reconstitute the immature B and T lineage
cells, but are still deficient in more mature T and B
lineage cells. Later on, the further differentiation of com-
petent, “compensated” progenitors finally generates the
more mature cell sets, as found in Group III mice. Thus,
the same initial LSK deficiency that was “compensated”
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Fig. 2 The bone marrow cells from Ccnd1Δ1-3 mice. a, b Dot blots are from one representative experiment showing 4-weeks-old littermates
belonging to different Groups studied simultaneously. Bar graphs represent the yield/femur of the different cell populations and are the mean
+/− SE of all the mice we studied: GrI (15) GrII (12) GrIII (18). a B220+ B lineage cells. b Lineage negative (Lin−: CD3−CD4−CD8−CD19−TER119−Gr1−
Mac-1−NK1.1−) progenitors analyzed according to their expression of IL-7R, Sca-1 and CD117. Upper graphs: CLPs; Lower graphs: LSK/HSCs. The
numbers in the dot-plots represent yields/femur. c Dot-plots are from one representative experiment showing 9-days-old WT and Ccnd1Δ1-3
littermates. Bar graphs are the mean+/SE of yields/femur all the 9-days-old mice we studied (n = 3). Upper graphs show LSK/HSC, lower graphs
erythroid and myeloid lineage cells. Statistic significance: *p < 0.05; **p < 0.005; ***p < 0.001
Chaves-Ferreira et al. Biology Direct  (2016) 11:21 Page 6 of 21can generate the different Ccnd1Δ1-3 mice phenotypes.
Each of these phenotypes actually represents “snap
shots”, taken at different time points after the occur-
rence of the LSK “compensatory” event/s.The expression of D cyclins in Ccnd1Δ1-3 mice
To investigate the mechanisms responsible for the modi-
fications in hematopoietic differentiation in Ccnd1Δ1-3
mice, as well as the compensatory mechanisms ensuring
the survival of Group III mice, we studied how the vari-
ous members of the D cyclin family were expressed in
the different Groups of mice. Besides mRNA coding for
cyclin D2 (Ccnd2) and D3 (Ccnd3) we also evaluated the
expression of Ccnd1 exons 4–5, since these domains are
not deleted in Ccnd1Δ1-3 mice and were shown to have
transcription regulatory activities.
Several mechanisms could explain the expression of a
truncated D1 molecule, coded by these 2 exons. It is well
known that the introduction of the neomycin cassette as
a strategy to generate deficient mice induces perturba-
tions at and around the insertion locus [18]. Current
gene ablation strategies always delete the neomycin in-
serts, but this was not done in Ccnd1Δ1-3 mice. The neo-
mycin cassette has potential transcription initiating sites,
which could lead to the transcription Ccnd1 exons 4–5.
Moreover, Ccnd1 exon 4 is known to have transcription-
initiating sites allowing transcription of exons 4–5. In
humans (in which D1 has 85 % homology with mouse
D1) these two exons, as well as exon 5 alone can be
transcribed independently [19].
We compared Ccnd expression in CD8+ T cells before
and after activation with anti-CD3ε mAbs. We chose
these cells to analyze a homogeneous population, pre-
venting the variations in the relative expression of D1 in
different cell types (Fig. 3). Moreover, CD8+ T cells facili-
tate the study of Ccnd expression after activation, since
these cells can be readily activated in vitro with anti-
CD3ε mAbs. In Group I mice, 4–5 Ccnd1, Ccnd2 and
Ccnd3 were virtually undetectable in both resting and
activated cells (Fig. 4a). These results indicate that
Group I mice are fully D1 deficient and, besides, that
they also do not express other D type cyclins. By con-
trast, resting cells from Group III “compensated” mice
transcribed 4–5 Ccnd1, Ccnd2 and Ccnd3 at WT levels.After activation, these mRNAs expression levels of were
upregulated to higher levels than in WT cells (Fig. 4a).
Besides the quantification of mRNA expression, we
also studied protein expression by confocal micros-
copy. For that purpose, we used a mAb raised by
immunization of rats with a polypeptide from the C
terminal mouse D1 molecule. This mAb fails to cross
react with either with D2 or D3 [20]. To demonstrate
the specificity of this mAb, we studied in parallel CD8 T
cells from group I and group III mice. The CD8 T
cells from Group I mouse failed to show any labeling,
while all CD8 T cells from Group III mice were la-
beled (Fig. 4b, Upper graphs). These results demon-
strate that this mAb only recognizes D1 4–5. Indeed,
if this mAb would recognize other proteins besides
D1, one would expect some labeling in cells from
Group I mice, but no labeling was detected, demon-
strating that this mAb only recognizes D1. By con-
trast, this mAb labels all cells of compensated mice.
Since compensated mice are D11–3 deficient, this
mAb cannot label 1–3 that is not there, it must label
4–5. We conclude that compensated mice do express
4–5 proteins, which migrated to the nucleus after ac-
tivation (Fig. 4b, lower left panel) and interacted dir-
ectly with the DNA (Fig. 4b, lower right panel).
Therefore, while Group I mice are fully D1 deficient,
Group III “compensated” mice express a truncated
D1 molecule corresponding to the C-terminal regulatory
domain, coded by the Ccnd1 exons 5 or 4–5. Due to the
rarity of Ccnd1Δ1-3 mice and the variability of their
phenotype we could not recover sufficient protein to
perform WB in these mice. We thus determined if the
independent expression of 4–5 was a normal process
also occurring in WT mice. Western blot analysis of
CD8+ WT cells using an polyclonal Ab recognizing the
C-terminal D1 region, shows the presence of two pro-
teins with a MW of about 14 and 16.5Kd as expected
from the independent translation of exons 5 and exon
4–5 respectively (Additional file 1: Figure S1). With this
Ab, a longer exposure time was required to reveal the
34Kd 1–5 D1 protein (not shown). These results suggest
that the independent expression of various isoforms of
D1 may not be a peculiarity of Ccnd1Δ1-3 mice, or of human
transformed cells [19]; it may be an event also occurring
in WTcells.
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Ccnd1
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B
Fig. 3 The expression of Ccnd1 in mice of different ages. The individual subpopulations of hematopoietic lineage cells were sorted from WT mice
with different ages (a). Quantification of Ccnd1 and Ccnd2 transcripts in different subpopulations of hematopoietic cells from 9-days and 4-weeks-
old WT mice. Results show the mRNA expression of the Ccnd1 and Ccnd2, determined by RT-qPCR, as referred to the RPII house-keeping gene.
They are the mean+/− SD of three independent samples. Please note: Since the different PCR amplifications had the same efficiency, the
expression levels of individual Ccnd can be directly compared. b Quantification of Ccnd1 in LSK, TN1 and CD19+IgM−CD43+ precursors of
15-days-old fetus (F) and 4-weeks-old adult (A) mice, as referred to the GAPDH house-keeping gene. Results show the mean+/− SD of from three
independent samples. SD deviations are too small to be visualized with the present scale. Statistic significance: *p < 0.05 (paired student t-test)
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ferent phenotypes of Ccnd1Δ1-3 mice. Group I mice are
fully D1 deficient, but also do not express Ccnd2 and
Ccnd3. These results indicate that the D1 cyclin controls
the transcription of Ccnd2 and Ccnd3 in hematopoietic
cells, as suggested by the highly significant binding ofD1 to the Ccnd2 and Ccnd3 promoters [9]. To further
confirm the absence of D cyclins in these mice, we stud-
ied the capacity of cells from Group I mice to divide. In
the absence of all D cyclins, hematopoietic cells should
be unable to divide. Indeed, this was the case. Group I
mice showed a profound block in BrdU incorporation in
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RPII housekeeping gene expression levels were similar in all mouse Groups. Results are the mean+/− SD of three independent experiments.
Statistic significance: *p < 0.05; **p < 0.005; ***p < 0.001 (paired student t-test). In each experiment amplifications from different Groups were
performed simultaneously. b Expression of truncated 4–5 D1 protein by resting CD8+ T cells from Group I (upper left panel) and Group III mice
(upper right panel); by activated CD8+ T cells from group III mice (lower panels): lower right panel show 4–5 migration into the nucleus and lower
left panel the interaction with the DNA (in grey) upon T cell activation. The 4–5 D1 fragment was identified with rat anti-mouse D1 4–5 fragment
mAb from ProMab Biotechnologies, Richmond, USA, revealed with a goat anti-rat Ab (Molecular Probes). The nucleus was labeled with DAPI and
is shown in Red. Co-localization analysis was performed using the Image J program
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the BM, mature T and B cells yet showing reduced div-
ision rates (Fig. 5). In contrast, the remaining Groups
express truncated 4–5 D1 molecules. In response to en-
vironmental stimuli these cells show a major up-
regulation of 4–5 Ccnd1 and other D cyclins, which
could eventually lead to an increased division rate andlymphoid hyperplasia. Indeed, we found an increased
BrdU incorporation in cells from Groups II and III mice
(Fig. 5). By contrast we found no evidence of increased
cell death in any of these populations (Additional file 2:
Note 1 and Additional file 1: Figures S2 & S3).
These results indicate that the cyclin D1 is a master
regulator of hematopoiesis. Moreover, the high division
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Fig. 5 Division rates of hematopoietic lineage cells from Ccnd1Δ1-3 mice. Results show BrdU incorporation in different cell types, defined at the
top of each column. In thymocytes and bone marrow cells, BrdU incorporation was evaluated after a 2 h pulse. In peripheral T and B cells, BrdU
incorporation was studied in mice receiving 2 BrdU injections/day spaced by twelve hours during three days. Barriers for positive cells were
established in the same populations from mice that were not injected with BrdU, labeled simultaneously. Results are from one experiment out of
4 giving the same results. Please note: Since each mouse must be studied individually we could not evaluate BrdU incorporation in CLP or LSKs,
which are too rare to allow identification of BrdU labeling in individual mice
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tory domain is responsible for controlling the expression
of D2 and D3, and thus the hematopoietic division and
differentiation. We thus used other strategies to demon-
strate these hypotheses directly.
Elimination of the full Ccnd1 blocks hematopoietic
differentiation
Since Group I mice are fully D1 deficient and showed
a major block in hematopoietic differentiation, cyclin
D1 could be fundamental for hematopoietic differenti-
ation. To directly demonstrate this, we eliminated the
full Ccnd1 by RNA interference. We generated several
lentiviral constructs expressing small hairpin RNAs
(complementary to Ccnd1 or scrambled control) and
EGFP as reporter. Using a T cell lymphoblastic cell
line, we selected one of these constructs, which in-
duced a 90 % down-regulation of Ccnd1 expression(Additional file 1: Figure S4). We compared the
in vivo and in vitro behavior of adult LSKs trans-
duced with this construct or a control one. Inhibition
of Ccnd1 expression by RNAi reproduced the differ-
entiation blocks found in Group I, fully D1 deficient
mice. In vivo, the thymus DP compartment was much
reduced. The TN differentiation was blocked at the
TN1-2 differentiation stages (Fig. 6a) as found in
Group I mice (Fig. 1b). In the BM, we found the
same pre-pro-B differentiation block, pro-B and pre-B
cells virtually disappearing (Fig. 6a). In vitro, when
LSKs were differentiated into T lineage cells in the
presence of the OP-9 Delta-like 4 stromal cell line,
we failed to generate TN2 cells or DP thymocytes
(Fig. 6b). When LSKs were cultured in B cell lineage
differentiation conditions with the OP-9 cell line, we
found a major block in the generation of B220high
cells; the vast majority of B220low cells did not
Fig. 6 (See legend on next page.)
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Fig. 6 Effects of cyclin D1 RNAi in LSK differentiation. Bone marrow LSK (Lin−Sca1+ ckithigh) progenitors were sorted from CD45.2+ mice BM, and
were transduced with either a cyclin D1 or a control shRNA-LV-EGFP. a They were directly injected into lethally irradiated (1,700 rad) CD45.1+Rag−
mice. Results show EGFP+ cells in four different individual mice two months after LSK transfer. Upper graphs: EGFP+ thymocytes; Lower graphs: B
cell lineage profiles in the BM, analyzed as described in Fig. 2. b They were cultured in in vitro conditions promoting T cell (upper graphs) or B/
myeloid cell differentiation (lower graphs). Results show the phenotype of EGFP+ at different time points after culture
Table 1 Ccnd1 4–5 over-expression increases lymphocyte
division
BrdU+ CD8 + T cells (%)
Experimental Group Mouse # Mean SE p
1 2 3 4
EGFP+ MOCK 20.0 13.5 10.7 30.6 18.7 6.6 0.01
EGFP+ D1 4-5 32.8 16.3 18.8 41.7 27.4 9.9
LSKs were purified from 5FU-treated CD45.1 and CD45.2 wild type mice.
CD45.1 LSK were transduced with a D1 4–5 coding retrovirus whereas CD45.2
LSK were transduced with the same control (Mock) virus. Equal numbers of
each transduced LSK were injected simultaneously into lethally irradiated Rag−
mice. 3 weeks after cell transfer, the proliferation rates of the EGFP+ CD8+T
subset were evaluated after 3 i.p. pulses of BrdU. Table 1 shows the % of BrdU
+ CD8+T cells generated from transduced LSKs (EGFP+) Mock (CD45.2) and D1
4–5 (CD45.1) in each individual mouse (n = 4). Differences in proliferation
between Mock and D1 4–5 transduced lymphocytes were evaluated by the
paired Student t-test
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found in Group I mice was reproduced (Fig. 6b).
These results formally demonstrate the master role of
the D1 cyclin in hematopoietic differentiation.
Overexpression of Ccnd1 exons 4–5 in hematopoietic
precursors increases cell division
To demonstrate directly the role of the truncated D1 4–5
molecule in hematopoiesis, one could express the 4–5
truncated molecule in the hematopoietic precursors of
group I mice, and study if this overexpression rescue
their phenotype. However, these experiments were im-
possible to perform and, importantly, could not give reli-
able results. We could not recover enough precursors to
achieve efficient infection and reconstitution. Group I
mice are quite young (what reduces the total number of
cells we can recover from the BM), virtually devoid of
progenitors, and these progenitors do not divide. Be-
sides, these mice are very rare excluding that we could
pool cells from several Group I mice to perform these
studies. But more importantly, these experiments were
unlikely to give straightforward conclusions. Since we
had to wait several weeks before the analysis of the pro-
geny of injected BM, and Group I rapidly compensate
their phenotype, both transduced and non-transduced
cells should show compensated phenotypes when tested
(Additional file 2: Note 2). Therefore, to correlate 4–5
expression to hematopoietic cells division we enforced
the expression of 4–5 in LSKs from WT mice. LSKs
overexpressing 4–5 or infected with an empty vector
were co-injected at the same number in lethally irradiated
Rag− mice. In the 4 mice we studied in two independent
experiments, the proliferation rate of peripheral CD8+ T
cells generated from 4–5 enforced progenitors was
higher (p = 0.01) than that of mock transduced cells
(Table 1). These results show that overexpression of 4–5
can modify division rates even in WTcells.
Conditional ablation of D1 4–5 prevents hematopoietic
differentiation
The other possible alternative to evaluate the role of 4–5
in hematopoietic cell division and differentiation, was
evaluating the effects of a deletion of 4–5. In these ex-
periments it was fundamental to demonstrate that the
deletion of 4–5 did not perturb the overall expression of
the D1 molecule, i.e., that by deleting 4–5 we were not
just generating a fully D1 deficient mice. Therefore, weuse an experimental strategy that should ensure the ex-
pression of D1 1–3 in 4–5 deleted mice. We generated
conditional deficient mice by introducing two loxP sites
flanking the 4th exon (Additional file 1: Figure S5). In
the selected strategy, after Cre recombination exon 4
should be excised completely. The further splicing of
exon 3 to the splice acceptor site of exon 5 introduces a
5′ stop codon, preventing the expression of the 5th exon.
This strategy was designed to allow the stable expression
of exons 1–3, since neither the splice acceptor site nor
the poly-adenylation sites of exon 5 are modified, which
should guarantee mRNA stability.
We crossed these mice with mice expressing Cre
under the Vav1 promoter (which induces Cre expression
in LSKs and all hematopoietic lineage cells) but had
major problems in generating a viable progeny Vav-Cre
Ccnd14-5flox+/+ progeny (Additional file 2: Note 3). The
very rare mice that had this genotype, expressed Ccnd1 1–3
but not Ccnd1 4–5 at early ages (4–7 days-old mice)
(Additional file 1: Figure S6A). These results clearly
demonstrated that the deletion of 4–5 did not perturb the
overall expression of the D1 molecule, since exons 1–3
were yet transcribed. Western blot analysis in older mice
using the DCS-6 mAb, that recognizes the D1 exon 3,
confirmed the presence of a truncated molecule with a
MW corresponding to the protein coded by Ccnd1 exons
1–3. It must be noted that we used this mAb previously,
and showed that it is fully D1 specific, i.e., it does not
recognize D2 or D3 or any other protein of the cell [20].
However, besides this truncated molecule, a band of
34Kd corresponding to the WT D1 protein was also
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the WT protein was still expressed in these mice, we
studied the kinetics of Cre expression by RT-qPCR.
While Cre expression remained stable in Vav1-Cre mice,
it rapidly declined in Vav1-Cre+/−Ccnd14-5flox+/+ mice
(Additional file 1: Figure S6C). We conclude that these
mice also compensated their Ccnd1 exons 4–5 deficiency
by the selection of the very rare hematopoietic cells failing
to express Cre.
To study the role of Ccnd1 4–5, we thus performed
competitive BM reconstitution experiments. To prevent
the emergency of compensatory events, these chimeras
were studied as early as at two weeks after BM transfer.
When lethally irradiated CD45.1+/CD45.2+ Rag− mice
were injected with identical numbers (2,500 cells) of
CD45.1+ WT and CD45.2+ LSKs from Vav1-Cre
+/−Ccnd14-5flox+/+ mice (hereafter referred as Vav cells),
only 7 % of the hematopoietic lineage cells were of Vav
origin. As expected, the frequency of CD45.2 Vav LSKs
was much reduced when compared to that of CD45.1
WT LSKs (Fig. 7a). WT CD45.1 cells generated B220high
B lineage cells while Vav precursors only generated
B220low precursors enriched in B220low CD43− precur-
sors (Fig. 7b), as found in Group I mice. In the thymus,
all WT thymocytes showed a coordinated differentiation,
TN precursors being at the CD44+CD25+ (TN2) and
CD44−CD25+ (TN3) differentiation stages (Fig. 7c). Vav
TN precursors in the thymus were virtually absent.
Their CD44/CD25 phenotype did not reproduce that of
WT TN cells (Fig. 7c-left) or they showed a major accu-
mulation of the CD44+ CD25− TN1 population, and a
major reduction of TN2 and TN3 cells (right), as found
in Group I mice (Fig. 1). These results confirm that the
elimination of Ccnd1 exons 4–5 blocks hematopoietic
differentiation, reproducing the phenotypes of fully D1
deficient, Group I mice.
Discussion
The present data emphasize the difficulty of evaluating
the role of fundamental molecules since their ablation
frequently increases mortality or/and leads to the emer-
gency of compensatory mechanisms, which may mask
ongoing major effects. Thus, the different phenotypes of
Ccnd1Δ1-3 mice were initially very perplexing. It was not
evident why the partial deletion of a single gene would
generate mice with such different phenotypes as Group
I, II, III mice. The reasons behind this heterogeneity be-
came clear, once we associated the mortality rates in this
colony at different ages, with the variations in both phe-
notypes and D1 expression levels. A substantial fraction
of Ccnd1Δ1-3 embryos died, indicating that this defi-
ciency can be embryonic lethal. Another large fraction
of mice died shortly after birth. The comparison of 9-
days and 4-weeks-old mice identified that the Ccnd11-3deletion affected LSKs in 9-days-old mice, inducing se-
vere reductions in erythroid and myeloid lineages. Thus,
mice often died during this period, since either erythroid
or myeloid lineages are required for survival. The higher
pre-natal and perinatal death of these mice is also justi-
fied by a much higher expression of Ccnd1 during these
periods, when compared to adult mice. After this critical
pre- and peri-natal period, mice survived if they recon-
stituted LSKs, erythroid and myeloid lineages. These re-
sults indicated firstly that the Ccnd11-3 deletion already
affected LSK generation, and secondly, that Ccnd1Δ1-3
mice developed one or several “compensatory” mecha-
nisms overcoming the LSK deficiency. This compensa-
tion not only increased LSK numbers, but also
generated competent LSKs as shown by their capacity to
reconstitute the erythroid and myeloid lineages in 4-
weeks-old mice. Moreover, “compensation” did not
occur simultaneously in all mice.
The asynchronous generation of competent LSKs in
Ccnd1Δ1-3 mice was sufficient to fully explain the differ-
ent phenotypes of individual mice from this colony.
Once competent LSKs are generated, these cells differ-
entiate progressively though this differentiation takes
time. Therefore, they will first generate the more imma-
ture hematopoietic cell sets. This explains the phenotype
of the Group II mice, which reconstitute the most im-
mature, but are still deficient in more mature, T and B
lineage cells. Later, the further differentiation of these
competent progenitors will lead to the generation of
more mature cells, as found in “fully compensated”
Group III mice, whose phenotype is largely equivalent to
that of normal mice. Thus, the same initial LSK deficiency,
when “compensated” at different time points in different
mice, is expected to generate the three different phenotypes,
which correspond to “snap-shots” taken at different time
points after the occurrence of the LSK “compensation”.
Our results also show why D1 is fundamental for
hematopoietic differentiation, and how “compensation”
occurs. We demonstrated that the hematopoietic differ-
entiation deficiency in Group I mice was indeed due to
the D1 deficiency, since we reproduced the same
hematopoietic differentiation blockages by eliminating
the full D1 molecule by RNAi. Concerning the mecha-
nisms, we found that fully D1 deficient Group I mice did
not transcribe Ccnd2 and Ccnd3. The absence of all
members of the D cyclins family in these mice is also
confirmed by a failure of their cells to divide, i.e.,
to incorporate BrdU. Indeed, all subpopulations of
hematopoietic lineage cells from Group I mice showed a
virtual absence of BrdU incorporation, while we found
no evidence that increased apoptosis contributed to their
reduced numbers, or to the hematopoietic differentiation
blockage. These results indicate that D1 controls the ex-
pression of D2 and D3, by regulating their transcription.
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Fig. 7 The progeny of WT and Vav1-Cre+/−Ccnd14-5flox+/+ LSKs in BM reconstituted chimeras. Lethally irradiated (1,700 rad) CD45.1+ CD45.2+ Rag2−
mice were injected i.v. with equal numbers (2,500) of LSKs from CD45.1+ WT and CD45.2+ Ccnd14-5flox+/+ mice, expressing the Cre recombinase
under the Vav1 promoter (Vav cells), and studied two weeks after BM transfer. Upper graphs show WT and lower graphs Vav cells (a). B220+ BM
cells (b). TN thymocytes. Results are from two independent experiments
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Ccnd3 was not unexpected. It is well known that D1 has
major roles in the regulation of gene transcription.
These roles do not depend on the conserved cyclin box
domain, but rather on the 3′ and 5′ regulatory domains.
In genome-wide Chip analysis, D1 was found to bind up
to 2840 putative sites of both proximal and distal pro-
moters [7]. In particular, it was shown that D1 binds the
Notch 1 promoter and regulates the expression of Notch 1[9]. Since D1 binds the Ccnd2 and Ccnd3 promoters
with a twenty fold higher significance (p value) than the
Notch 1 promoter [9], a role of D1 in transcribing Ccnd2
and Ccnd3 is to be expected.
Our analysis of compensated mice and of mice in
which the expression of exons 4–5 was eliminated by
homologous recombination indicates that the C-
terminal region of D1, coded by Ccnd1 exons 4–5, regu-
lates D2 and D3 transcription. This regulatory domain is
Chaves-Ferreira et al. Biology Direct  (2016) 11:21 Page 14 of 21well known to control gene expression [4–7]. This trun-
cated D1 was not eliminated in the construction of
Ccnd1Δ1-3 mice. Western blot analysis suggests that mature
T cells from WT mice also express truncated D1 molecules
coded by Ccnd1 exons 5 and 4–5, as it was reported in
human cells [19]. Interestingly, these truncated molecules
migrate to the nucleus after activation. Lastly, over-
expression of these two exons in WTcells increased division
rates, while the elimination of these exons by homologous
recombination compromised mice survival, and LSKs from
Vav1-Cre+/−Ccnd14-5flox+/+ fared very poorly in BM recon-
stitution chimeras. Although these chimeras were injected
with the same number of Vav1-Cre+/−Ccnd14-5flox+/+ and
WT LSKs, the number of Vav1-Cre+/−Ccnd14-5flox+/+ LSKs
was much lower than WT LSKs. Similar to full D1 deficient
mice, Vav1-Cre+/−Ccnd14-5flox+/+ LSKs showed a B-pro-B
differentiation block and were unable to generate TN
thymocytes, in contrast to WT LSKs.
Conclusions
To summarize, our data shows that the D1 cyclin has a
fundamental role in hematopoietic differentiation, being
required for the expression of the other members of the D
cyclin family and the generation of competent LSKs. Since
D2 is the most abundant cyclin in hematopoietic lineage
cells [21], the role of D1 cyclin as a master regulator of
early hematopoiesis excludes the notion that individual D
cyclin family members have fully redundant functions.
Previous observations performed on Ccnd3−/− mice sup-
port the same notion. Since these mice express both D1
and D2, fully redundant functions of all D cyclins would
be incompatible with the role of D3 in TN3-TN4 transi-
tion and in B cell differentiation [12, 13]. However, the
relative abundance of each D cyclin impacts on the effect
of D type cyclin deficiencies. In both D1 and D3 deficien-
cies, the major impact in hematopoiesis correlated to a
higher expression of these cyclins. Our results indicate a
temporal and differential role of each D-type cyclin in
hematopoietic differentiation. While D1 plays a role in
earlier multi-lineage progenitors, D3 affects B cell differ-
entiation and the TN3-TN4 transition in the thymus. The
strong progenitor default induced by the Ccnd1 deficiency
causes that the vast majority of the deficient animals to
die before birth or shortly after birth approaching the
lethal phenotype of Ccnd1Δ1-3Ccnd2−/−Ccnd3−/− mice [3].
Methods
Mice
CD45.2+C57BL/6 and CD45.1+/45.2+ Rag-2 deficient C57BL/
6 mice were bred at the Center for Development of Advanced
Experimentation Techniques, Orleans, France. Mice lacking
the Ccnd1 exons 1–3 (Ccnd1Δ1–3 mice) were kindly provided
by Dr. Sicinski [14]. Mice expressing the Cre recombinase
under the Vav1 promoter were a kind gift of Dr. A. Potocnik[22]. This study was performed in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the Ministère de l’Agriculture, de la
Pèche et de l’Alimentation, France. All of the animals were
handled according to approved institutional animal care and
use committee (IACUC) protocols of the Institut Necker
Enfants Malades, Faculté de Médecine Paris Descartes, Paris,
France. The Committee on the Ethics of Animal Experiments
of the University Paris V approved the protocol.
The breeding of Ccnd1Δ1-3 mice
Since Ccnd1Δ1–3 females are incapable of nursing due to an
impaired mammary gland development, and the Ccnd1Δ1–3
males have low sperm counts [14], Ccnd1Δ1–3 mice were
obtained by crossing heterozygous mice, in very special
conditions we adapted for the D1 deficiency. It must be
noted that these breeding conditions were fundamental to
obtain Groups I and II mice. In standard breeding condi-
tions most of the surviving progeny were WT or heterozy-
gous, homozygous mice being of smaller size, died shortly
after birth, the few survivals having compensated (Group
III) phenotype. The major problems of this breeding and
the strong selection pressure for “compensated” mice
explain why Groups I and II mice were rare in previous
colonies of Ccnd1Δ1-3 mice, being considered as outliers
and not investigated further [14].
Briefly, the breeding was done exclusively in isolators
and under continuous direct supervision. Since mothers
frequently kill fragile pups and/or WT littermates out-
compete them for feeding, Ccnd1Δ1-3 pups were identified
by their neurological abnormalities during the first days
after birth and transferred to WT foster mothers. We
found that their neurological abnormalities prevented
Ccnd1Δ1-3 mice from climbing to reach food and water,
while the dental abnormalities prevented feeding and the
ingestion of solid food. These handicaps may explain the
reduced size reported in these mice. Thus, when pups
reached three weeks of age the teeth were cut regularly
and wet soft food was directly provided every day to the
litter. Finally, couples were maintained for two litters only,
since both fertility and the number of Group I mice de-
clined with generations. Moreover, the maintenance of
this colony in isolators was mandatory, since contra-
selection of Group I mice occurred even with minor infec-
tions, which are not considered to lead to the loss of the
s.p.f status. In contrast to previous reports [14] when bred
in these conditions, the size and body weight of Ccnd1Δ1-3
mice was comparable to that of WT littermates.
Antibodies for flow cytometry, western-blots and confocal
analysis
The mAbs used for flow cytometry and/or cell sorting
(BD Pharmingen) were anti: CD4, CD3, CD8, CD44,
CD25, CD24, CD117, B220, CD43, Ter119, GR1, Sca-1,
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They were either directly conjugated to FITC, PE, APC,
PerCP or biotin, these later being revealed by
streptavidin-APC or PerCP5.5. To study cells in S phase
in central lymphoid organs mice received two i.p injec-
tions of 1 mg of BrdU (Sigma) at a 4 h interval. To
analyze proliferation in peripheral organs, mice were
injected with 1 mg of BrdU i.p. every 12 h during 3 days.
BrdU incorporation was detected using a FITC-
conjugated anti-BrdU antibody (BD Pharmingen).
The Abs used for Western blots recognizing mouse
Cyclin D1 used were: for the truncated 1–3 molecule,
the mAb DCS-6 (CellSignal #2926) generated by
immunization with a protein corresponding to aa 151–
170, localized in the Exon 3. We had previously used
this mAb extensively and confirmed it only recognized
D1, and did not cross-react with D3 and D3 [20]; a poly-
clonal rabbit Ab recognizing the C-terminal part of the
molecule (AbCam 7958).
To visualize the truncated D1 4–5 protein by confocal
microscopy, CD8+ T cells were placed in slides previously
coated with 0.1 % poly-L-Lysine (Sigma), then fixed with
2 % PFA, permeabialized with 0.15 % Triton and incu-
bated with Image-IT Fx signal enhancer (Molecular
Probes). These cells were then labeled with a rat anti-
mouse mAb purchased at ProMab Biotechnologies,
Richmond, USA. This mAb raised by the immunization of
rats with a recombinant protein corresponding to the C
terminal of mouse D1, not shared by D2 or D3 and the
manufacturer provided us evidence it did not recognize
D2 and D3. They were washed and incubated with a la-
beled goat anti-rat Ab (Molecular Probes). Slides were
overlaid with coverslips in Vectashield® mounting medium
(Vector) which contains DAPI for nuclear staining, shown
in Red. Confocal microscopy was performed with the
Zeiss LSM700 axioplan microscope (Carl Zeiss Micro-
Imaging GmbH, Germany). The same cell populations in-
cubated with the goat anti-rat Ab were used to determine
background staining. The interactions between 4–5 poly-
peptide and the DNA were evaluated by the Image J pro-
gram and are shown in grey.
Western blot analysis
Western blots were performed with 3x106 CD8+T cells
that were lysed in modified RIPA buffer (50 mM Tris/
HCl pH 8, 200 mM NaCl, 1 % Nonidet P40, 0.5 % deox-
ycholate, 0.05 % SDS, 2 mM EDTA), 1 mM orthovana-
date and a protease inhibitor cocktail (Roche Diagnostics).
A total of 30 μg of proteins were separated by 15 %
SDS-PAGE. After blocking, membranes were incu-
bated with either the anti-Cyclin D1 DCS-6 mAb rec-
ognizing both mouse and human D1 exon 3 or with
an Ab against the C-terminal part of the molecule
(AbCam 7958). Abs were diluted in 5 % non-fat milk,1x PBS, 0,1 % Tween-20 and membranes incubated
overnight at 4 °C with gentle shaking. Immunoblots
were analyzed by ECL with the Western Lighting
Chemiluminescence Reagent Plus (PerkinElmer) and re-
vealed by Fuji Image Quant LAS-4000. For re-bloting with
actin, blots were stripped in 0.2 M glycine (pH2.5) for
30 min at room temperature and re-bloted with monoclo-
nal anti-actin (Sigma-Aldrich, clone AC-40). Intensity of
the bands was analyzed using ImageJ 1.48v software.
RT-qPCR and shRNA-Lentivirus
Primers used for RT-qPCR were selected in order to in-
clude at least one intron in the amplicon, no match with
other murine genes by standard blast, no genomic amp-
lification and for identical amplification efficiency. Re-
sults shown in Fig. 3b were obtained from samples of 50
sorted cells, using the single cell RT-qPCR techniques
we described previously [23]. Oligonucleotide sequences
are shown in Additional file 3: Materials.
For the production of lentivirus vectors we used the
pLV-HTM plasmid (kindly provided by Dr. Trono
Didier, Geneva University) which is a self-inactivation
third generation HIV1-derived vector [24]. The annealed
oligonucleotides coding for shRNA were ligated into
ClaI and MluI double-restricted plasmid by standard
cloning procedures, using restriction enzymes and T4
DNA ligase (New England BioLabs Inc). In these condi-
tions, the production of siRNA is under the control of
H1 (RNA polymerase type III) promoter, and the re-
porter gene, the green fluorescent protein (EGFP) is
expressed under the control of eukaryotic EF-1α pro-
moter. All plasmids were verified by sequence analysis.
Lentivirus particles were produced by transient transfec-
tion of 293 T cells according standard protocols. Briefly,
subconfluent 293 T cells were co-transfected with 20 μg
of plasmid vector, 15 μg of pCMVR8.74 and 5 μg of
pMD.G envelope (VSVG) by calcium phosphate method.
After overnight incubation, medium was changed for a
fresh one and supernatants were harvested at 48 and
72 h. Supernatants were further concentrated (100X) by
ultracentrifugation, titrated and stored at −80 °C until
use. Viral titers expressed as TU/ml were determined by
assessing transduction of 293 T cells with serial dilutions
of virion preparations. Batches with titers ≥108 TU/ml
were used.
Cloning of Ccnd1 exons 4–5 and retrovirus production
RNA was extracted from purified lymph node CD8+T
cells after 24-h anti-CD3 activation using RNeasy Plus
kit (Qiagen) and retrotranscribed with MuLV from the
GeneAmp RNA PCR kit (Applied Biosystems). This
cDNA was used as template for the cloning PCR using
the high fidelity proof reading Pfu Turbo Polymerase
(Stratagen) with the cloning primers (see Additional file
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in a passenger pCR®-Blunt II TOPO® vector (Thermo-
Fisher Scientific) and sequenced. This passenger vector
was further restricted with MfeI and SnaBI enzymes
(New England Biolabs) and cloned into pMiev retrovirus
vector. PlatE virus packaging cells were transfected with
pMiev (empty or Ccnd1 4–5) in presence of lipofectamin
LTX (Invitrogen). Media was changed at 24 h and super-
natant harvested two days after, filtered onto 0.45 μ and
used to transduce purified LSK.Purification, transduction and differentiation of
hematopoietic progenitor cells
CD45.2+ (or alternatively CD45.1+) C57BL/6 mice were
injected i.v. with 100 mg/kg 5FU (TEVA Pharma). Bone-
marrow (BM) cells were recovered 5 days later and de-
pleted of Lineage positive cells with a cocktail of rat
mAbs (anti CD11b, CD8, CD5, CD45R/B220, Gr-1,
Ter119) and anti-rat IgG conjugated dynabeads (Dynal).
Hematopoietic progenitors were further enriched using
the Spin Sep Purification kit (Stem Cell Technologies)
following manufacturer instructions. Using this double
step procedure, LSK progenitors were enriched 200
times with a recovery of 80 % of the initial progenitor
cells after the procedure.
Transduction of enriched progenitors was per-
formed in the presence of 5 μg/ml of protamine
sulphate (Sigma) and 10 μg/cm2 coated RetroNectin®
(Takara). Briefly, 1x106 enriched progenitors were
plated in 96 well plate in 200 μl of complete RPMI
media (Gibco) in the presence of 10 ng/ml SCF,
50 ng/ml TPO, 100U/ml IL-6, 10 ng/ml IL-11 and
5 ng/ml Flt3-L, all recombinant murine cytokines
from R&D Systems. Virus supernatants were added at
a multiplicity of infection MOI = 10. Plates were cen-
trifuged at 1000 g during 1 h at 20 °C and further
cultured at 37 °C for other 4 h. At the end of this
5 h transduction protocol, cells were extensively
washed and injected into lethally irradiated CD45.1+
Rag− mice or cultured “in vitro”, in conditions pro-
moting either myeloid/B cells or T cells development.
Myeloid and B cells development was performed by
co-culture of these progenitors on OP9 stroma cell
line whereas T cell development was induced by co-
culturing progenitors on OP9-DL4 stroma (a kind gift of
A. de la Coste) as previously described [25]. Briefly, OP9
or OP9-DL4 cells were seeded into 6-well tissue culture
plates the day before the co-culture with progenitors. All
cultures were performed in presence of 1 ng/ml IL-7 and
5 ng/ml Flt3-L (both recombinant murine cytokines from
R&D Systems) and fed every 4 days. At the indicated time
points, cells were harvested, counted and their phenotype
evaluated by cytometry.Conditional deletion of Ccnd1 exons 4–5
The Ccnd1 exons 4-5flox+/− mice line was established at
the Mouse Clinical Institute (Illkrich, France) by trans-
forming C57BL/6NTac embryonic stem cells with a line-
arized conditional targeting vector. This vector (shown
in Additional file 1: Figure S5) was constructed to delete
the Ccnd1 exon 4, by flanking it with two loxP sites, one in-
troduced in intron 3 and another in intron 4. Deletion of
the flanked exon by Cre mediated homologous recom-
bination results in a frame-shift mutation of exon 5 with
an early stop codon. This strategy was selected to main-
tain a normal expression of the Ccnd1 exons 1–3, since
for the stability of the respective mRNA after splicing it
was important to keep the splice acceptor site of exon 5
and the poly-adenylation signals, otherwise RNA decay
was likely to occur. The neomycin resistance gene (Neor)
under the control of the PGK promoter (PGK-Neor) was
inserted into intron 4 upstream the loxP site. Two FRT
sites flanked pGK-Neor. The 3480 bp genomic fragment
5′ upstream of exon 4 and the 3509 bp 3′ of exon 4
were amplified by PCR and used as 5′ and 3′ homology
arms. 186 neomycin resistant clones were screened for
homologous recombination by PCR using 3 primer
pairs, composed of external primers and vector specific
primers. 6 positive clones were obtained. Positive clones
were further confirmed by southern blot using a Neor
probe and a 5′ external probe. Correctly targeted clones
were transiently transfected with a Flp expression vector
to delete the PGK-Neor gene and the progeny clones that
became Neomycin sensitive were confirmed by PCR.
The correct disposition of the target vector was further
confirmed by sequencing. Clones containing exon 4
flanked by two loxP sites and lacking Neor were microin-
jected into C57BL/6 J blastocysts to generate conditional
Ccnd1 exon 4 and 5 knockout mice. Three female mice
with germ line transmission were obtained. Two of these
mice did not generate any progeny, i.e., all floxed mice
issued from a single mouse. We sequenced the modified
gene and excluded that any epigenetic/genetic event
could have modified the loxP sites in this founder female
mouse.Bone marrow reconstitution experiments
CD45.1/45.2 B6 Rag−/− mice were irradiated lethally
(1,700 rad) and injected i.v. with 5,000 sorted LSKs
(2,500 from CD45.1+ WT B6 donors and 2,500 from
CD45.2 Vav1-Cre+/−Ccnd14-5flox+/+ mice). Mice were
maintained in water supplemented with neomycin one
week before and 1 week after irradiation.Statistic analysis
Prism software (GraphPad) was used. Two groups were
compared with the Student t-test for paired data. P
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Reviewers’ comments
Reviewer #1 Dr. Manabu Sugai (Kyoto University, Japan)
We thank the reviewer for the thorough review of our
manuscript. To simplify the reading of our answers to the
reviewer’s comments, we transcribe directly these com-
ments followed by our answers in italic. The modifica-
tions in the Ms. are in red.
Reviewer summary
The manuscript by Chaves-Ferreira et al. addresses the
specific function of cyclin D1, which cannot be
substituted by other cyclins. The authors found that in
addition to full-length cyclin D1, the carboxyl terminal
region (exons 4 and 5) of cyclin D1, which the authors
designate as the 4–5 proteins, was independently
expressed. The 4–5 proteins may promote the transcrip-
tion of cyclins D2 and D3 as transcriptional activators.
The authors noted the variegated phenotypes of cyclin
D1d1-3-deficient mice, and after examining the differ-
ences between them; they concluded that the expression
levels of the 4–5 proteins are the cause of the variegated
phenotypes observed in cyclin D1d1-3-deficient haem-
atopoietic cells. The proposed concept is very interest-
ing, but I have few concerns with the methodology and
interpretation of the data.
Reviewer recommendations to authors
This is a very interesting manuscript that demonstrates
the special function of cyclin D1, which is performed by
the 4–5 proteins. To understand the physiological sig-
nificance of the findings, the authors need to show more
convincing evidence of the existence of the 4–5 proteins
in wild-type cells. The expression of the 4–5 proteins in
activated CD8 T cells from cyclin D1d1-3 mice was de-
termined by immunostaining using anti-4-5 D1 mAb
(Fig. 4b).
Comment 1
To confirm the specificity of this antibody, the expres-
sion of the 4–5 proteins in VAV-Cre+/−cyclin D1d4-
5:flox/flox CD8 T cells from BM-transferred RAG2−/−
mice is required. In addition, same experiment using
wild type CD8T cells will be required. It is ambiguous
whether the epitope of mAb (DCS6) recognizes exon 3
or the C-terminal part of cyclin D1 (as described in the
materials and method section). Therefore, the specificity
of DCS6 mAb needs to be determined. The existence of
the 4–5 proteins was demonstrated by Western blot
analysis of WT-CD8 T cells using DCS6 mAb antibody
(Additional file 1: Figure S1). Lysate from VAV-Cre+/−cyclin
D1d4-5:flox/flox CD8 T cells is an appropriate negativecontrol to validate the 4–5 proteins that were identified in
Additional file 1: Figure S1.
We think these queries result of an incomplete descrip-
tion of the Abs we used in these studies, what could have
lead to misunderstandings. In the revised version of the
Ms, we clarified in both the Materials and Methods sec-
tion (page 19, in red) as well as in the Fig. legends (page
25, Fig. 4 legend, page 29, Additional file 1: Figure S1
legend, in red) the three different commercial antibodies
against cyclin D1 that we used in this study.
a) The Ab used for WB analysis in Additional file 1: Figure
S1, (to identify the expression of 4–5 by WT CD8 T
cells) was NOT DCS-6, but a polyclonal rabbit Ab
recognizing the C-terminal part of the molecule (from
AbCam: ref Ab7958). Although we do not show the
results, we obtained similar data with another com-
mercial polyclonal Ab from Cell Signaling (reference
2922) also sold as recognizing the C-terminal part of
the D1 molecule.
b) The mAb DSC-6 (BD pharmingen) that recognizes an
epitope in both mouse and human D1 exon 3 was
only used for the WB analysis of Vav1-Cre+/−Ccnd14-
5flox+/+ mice, shown in Additional file 1: Figure S6B.
This study was performed to show that after 4–5
ablation, the D1 1–3 truncated molecule was yet
expressed. This control was important, since it was
possible that the 4–5 deletion perturbed the
expression of the Ccnd1 gene, i.e., by deleting 4–5 we
were just generating a full D1 KO mouse.
c) For confocal microscopy, we used a rat anti-mouse
mAb recognizing the truncated D1 protein coded
by exons 4–5, sold by ProMab Biotechnologies,
Richmond, USA.
All these Abs are commercial, and we expect that these
respected companies have tested their specificity. Our WB
results confirm the reported specificities, since they recog-
nized the respective proteins at the correct sizes. It is not
possible to verify the specificity of all the commercial Abs
used for cytometry or WB. Considering the high amount of
protein required for sequencing, and the multiple Abs usu-
ally used in each Ms. this would be an impossible task.
We believe therefore that this query was due to a mis-
understanding/poor description of the Abs used and their
reported specificity. Besides, the confirmation of the Ab
specificity in Vav1-Cre+/−Ccnd14-5flox+/+ cells in BM chi-
meras is impossible to perform, taking into consideration
the minute number of Vav cells recovered from these chi-
meras, and the absence of CD8 T cells.
Comment 2
The functions of the 4–5 proteins were not directly de-
termined in this manuscript. This is another problem
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script. As shown in Fig. 4a, the expression levels of the
4–5 proteins were well correlated with those of cyclins
D2 and D3. However, the authors did not examine
whether the expression of cyclins D2 and D3 was due to
the expression of the 4–5 proteins. To reveal this, the
4–5 proteins should be introduced into cyclin D1d1-3
LSK cells via lentivirus to estimate the effects in tran-
scription of cyclin D2 and D3 mRNAs. Please show the
functional importance of the 4–5 proteins in cyclin D2
and D3 expression.
We now included in the text (page 12, in red) the direct
response to this comment: these experiments cannot pro-
vide adequate information. We had already explained
the serious limitations of these experiments in detail in
Additional file 2: Note 2- why these experiments cannot
give conclusive results; note that we transcribe bellow:
Additional file 2: Note 2: To directly demonstrate that
the truncated D1 4–5 molecule has a role in
hematopoiesis and in the expression of D2 and D3, two
strategies could have been used. One would be to induce
the expression of the truncated protein in the
hematopoietic precursors from Group I mice and demon-
strate that this over-expression would rescue their pheno-
type, as well as D2 and D3 expression. However, this
approach was virtually impossible to perform, and could
not give reliable results. It was virtually impossible to
perform because Group I mice are quite young (what re-
duces the total number of cells we can recover from the
BM), and virtually devoid of progenitors. Besides, these
mice are very rare excluding that we could pool several
Group I mice to obtain the enough precursor cells to
achieve efficient infection and reconstitution. But more
importantly, these experiments could not give straightfor-
ward conclusions, because both transduced and non-
transduced cells should show compensated phenotypes
and normal D2 and D3 expression when studied. Indeed,
Injected BM progenitors take one month to generate the
various thymocyte sub-populations and two months to
reconstitute the peripheral pools. Therefore, injected mice
in these experiments should be studied two months after
the transfer of progenitors, i.e. when these mice will be
around 10-weeks-old. However, as we state in the 2nd
chapter of results section, Group I mice compensate their
Ccnd1 deficiency by 6 weeks of age. Therefore, non-
transduced cells should have also have the compensated
phenotype when studied in 10-weeks-old mice, i.e. would
be identical to transduced cells. In transduced cells also
showing a compensated phenotype, it would be impos-
sible to attribute this compensation to the expression of
Ccnd1 4–5 we had induced or to any other non-
identified compensatory mechanism that would be en-
gaged in compensated, non-manipulated mice. Therefore,
the only possible strategy to address the role of 4–5 wasto generate 4–5 deficient mice. Since this molecule was
likely important during embryogenesis, we generated con-
ditional deficient mice.
To further detail this point: We agree with reviewer
that this kind of experiments could be an important
functional clue. However, as explained in the Additional
file 2: Note 2 and described in page 6–7, Ccnd1Δ1–3
Group I LSKs have to be recovered from very young mice,
which have yet few cells in the BM and are practically
devoid of LSK. Cell loss is considerable in sorting rare
populations, so we could recover less than 103 LSKs after
sorting. This makes transduction and reconstitution very
difficult, since Group I mice are rare, so we cannot pool
several Group I mice to increase the number of precur-
sors available.
But the major problem of this experiment is that read-
outs would not provide any reliable conclusions. Since
Group I mice that survive compensate their deficiencies
by rapidly expressing 4–5, it is likely that both trans-
duced and non-transduced cells would express 4–5 and
Ccnd2 and Ccnd3 after the long time period required to
wait for BM reconstitution. It would be impossible to at-
tribute these expressions to the 4–5 molecule we had in-
troduced or to any other non-identified compensatory
mechanism.Reviewer #2 Dr. Wayne Hancock (University of
Pennsylvania, USA)
Reviewer summary
This is an interesting and well-written report showing
that members of the cyclin D family of proteins (D1, D2
and D3) can have distinct, non-redundant roles. This is
a fine effort.Reviewer recommendations to authors
No recommendations for additional studies are
necessary.Minor issues
None
We thank reviewer for the thorough review of our
manuscript.Answers to re-revisions
Please find enclosed the answers to the reviewer’s com-
ments. To simplify the Editors and Reviewer’s tasks, we
transcribe each of the reviewer’s comments, followed by
our answer to each comment. The modifications intro-
duced in the text are shown with a yellow background.
We thank the reviewer for his work, and hope the modi-
fications introduced meet with his approval.
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First comment
Thank you for including the detailed information per-
taining to antibodies used in each experiment. I
apologize for misunderstanding about the antibodies.
However, one of the most important issues to be
shown is the convincing evidence of the existence of
4–5 proteins. Commercially available antibodies were
tested for specificity by detecting full-length cyclin
D1, but almost all the antibodies could also detect
the non-specific proteins. As shown in this manu-
script, the 4–5 proteins were newly identified, but the
bands that formed around 15 kDa using these anti-
bodies were not previously verified by the antibody
suppliers. For this reason, the authors need to show
that the bands detected by the antibodies (Ab7958,
2992) genuinely represent the 4–5 proteins. To sup-
port this, mouse embryonic fibroblasts (MEF) derived
from cyclin D1d4-5:flox/flox mice would be useful.
Cre-transduced cyclin D1d4-5:flox/flox MEF are an
appropriate negative control for verifying the 4–5
proteins. The authors need to verify the existence of
the 4–5 proteins by immunoblotting assay using three
antibodies (Ab7958 from Abcam, 2992 from Cell Sig-
naling Technology, and rat anti-mouse mAb from
ProMab Biotechnologies) and compare the lysates
from Cre-transduced and non-transduced cyclin
D1d4-5:flox/flox MEF. Confocal microscopic images
of Cre-transduced and non-transduced cyclin D1d4-
5:flox/flox MEF are also required.
1) To summarise comment #1: The reviewer objects
that we did not demonstrate that wild type cells and
the cells from Ccnd11-3 compensated mice
expressed the protein coded by 4–5 exons of D1
because we did not demonstrate the specificity of
the Abs using an appropriate negative control. 2) To
summarise this comment, the reviewer indicated
that the truncated D1 molecule (cyclin D11-3),
which is produced by an ablation of 4–5, might lose
some functions of the full length cyclin D1.
We believe our Fig. 4 demonstrates clearly that “com-
pensated” mice express a truncated D1 4–5 molecule. In
this experiment we used a mAb raised against 4–5 to
study 4–5 expression. The commercial firm that sold us
this Ab, send us data showing that this Ab does not
cross-react with D2 and D3. It was however possible that
the Ab would recognize any other protein expressed by
the cell, what would invalidate our results.
Our controls for specificity were the cells from Group
I, fully D1 deficient mouse. If this mAb would recognize
other proteins besides D1, one would expect some label-
ing in cells from Group I mice, but no labeling wasdetected, demonstrating that this mAb only recognizes
D1. By contrast, this mAb labels all cells of compensated
mice. Since compensated mice are D11–3 deficient, this
mAb cannot label 1–3 that is not there, it must label 4–5.
We conclude that compensated mice do express 4–5
proteins, which migrate to the nucleus after T cell acti-
vation and bind to the DNA. We now add this com-
ment to the revised Ms, page 9 last paragraph and
page 10 first paragraph.
Since in contrast to this mAb, the polyclonal Abs used
in WB recognize multiple cellular proteins, we tuned
down our conclusions concerning the expression of 4–5
in WT cells. We now state that the WB suggests the in-
dependent expression of 4–5 in WT cells (see page 10,
second paragraph).
The experiments suggested by the reviewer would re-
quire the back-cross of the Vav-Cre+ 4–5 flox/flox mice to
WT mice to eliminate Vav Cre, followed by the inter-
cross of 4–5 flox+/− mice to obtain flox/flox mice, the prep-
aration of embryonic fibroblast lines, the transfection of
these lines with Cre. These experiments required a vast
breeding program that would take months and could be
compromised by the serious breeding problems of the
Vav-Cre+ 4–5 flox/flox line. We here show that they are
not required to demonstrate the important point that
compensated mice express the 4–5 protein.
Second comment
The authors mentioned that the 4–5 proteins may pro-
mote the transcription of cyclins D2 and D3 and rescue
the defect observed in cyclin D1d1–3-deficient
hematopoietic cells. Although the idea is of great signifi-
cance, the authors fail to describe whether the expres-
sion of the 4–5 proteins is a cause or a consequence in
rescuing this defect. As shown in Fig. 4a, the expression
levels of the 4–5 proteins were well correlated with
those of cyclins D2 and D3. According to these data, the
authors can also conclude that the expression levels of
cyclins D2 and D3 are the cause of the rescued pheno-
types observed in cyclin D1d1–3-deficient hematopoietic
cells. Therefore, the authors need to demonstrate that
the enforced expression of the 4–5 proteins rescue cyc-
lin D1d1–3-deficient hematopoietic cells. These data are
essential to get the manuscript published.
2) It appears this conclusion very unfair to this
extensive work. We have extensive data
demonstrating directly the role of D1 in
hematopoiesis including the block in hematopoiesis
by eliminating D1 by RNAi. The review cannot
ignore all this data, and does not context it. The
only point he objects is the role of 4–5. We had
previously explained why the enforced expression of
4–5 in D1 deficient mice was impossible to perform
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additional note. We now also include a summary of
these points in the text, page 12, last paragraph.
Second comment bis
In this regard, the generation of transgenic mice that
express the 4–5 proteins in hematopoietic cells is
required.
Rather than generating a transgenic mouse, we
enforced the expression of 4–5 in WT LSKs, what
should give equivalent results, but was faster to
perform. These cells were co-transferred together
with Mock transduced cells into lethally irradiated
Rag- mice. We compared cell division by BrdU in-
corporation in both populations of EFGP+ trans-
duced cells. We show in the new Table 1 (page 45),
that enforced expression of 4–5 significantly in-
creases division rates (see also page 12, last
paragraph, page 13, first paragraph), thus correlating
directly the over-expression of 4–5 to cell division
(see page 13, first paragraph).
Third comment
The authors examined the phenotype of VAV-Cre+/cyc-
lin D1d4-5flox/flox mice to study the function of the 4–5
proteins. This approach is not suitable to evaluate the
4–5 proteins, because cyclin D1 function might be af-
fected by the deletion of exon 4 and 5. Therefore, they
cannot exclude the possible involvement of full-length
cyclin D1 in the phenotypes observed in these mice.
3) To summarize this comment, the reviewer objects
that our experiments of BM competition, (where
BM cells from Vav-Cre+ 4–5 flox/flox mice behaved as
full D1 deficient cells) are not valid, since the condi-
tional ablation of 4–5 could have perturbed the ex-
pression of the full D1 molecule. In this perspective,
cells from Vav-Cre+ 4–5 flox/flox mice, rather than ex-
pressing a truncated D1 molecule coded by exons
1–3 could be fully D1 deficient.
We had demonstrated clearly that in creating the Vav-
Cre Ccnd14-5flox+/+ mice we were not just generating a
fully D1 deficient mouse: a) the experimental strategy we
used to generate these mice was designed to allow the
stable expression of 1–3 (see page 13, second paragraph,
in yellow); b) We clearly demonstrated that these cells
were not just full D1 deficient in Additional file 1: Figure
S6B. The western blots shown in this Fig. clearly show
the presence of a 1–3 band, labeled with mAb DCS-6
(see page 13, last paragraph and page 14 first paragraph).
The reviewer could object that we do not know the
specificity of this Ab, and that the commercial firm thatsells it did not tested it. Two firms sell this Ab, B&D
and Cell Signaling. While B&D provides no information,
Cellsignaling (reference #2926) describes the polypeptide
located in exon 3 used for immunization, and the ab-
sence of cross-reactivity with D2 and D3. IMPORT-
ANTLY I have a long-term experience with this mAb.
Prof. Sherr advised me to use it, due to its high quality.
We used it extensively in one previous publication that
we now quote (Veiga-fernandes & B. Rocha, Nat Immu-
nol 2004). We demonstrated no cross-reactivity with D2
and D3. Importantly, this mAb DOES NOT CROSS-
REACT WITH ANY OTHER CELL PROTEIN. The
WB analysis of total cell proteins only shows the D1
band. Therefore, our results demonstrate that the Floxed
mice express the truncated D1 molecule corresponding
to exons 1–3.
Reviewer #2 Dr. Wayne Hancock (University of
Pennsylvania, USA)
Reviewer summary
This is an interesting and well-written report showing
that members of the cyclin D family of proteins (D1, D2
and D3) can have distinct, non-redundant roles. This is
a fine effort.
Reviewer recommendations to authors
No recommendations for additional studies are necessary.
Minor issues
None
We thank both reviewers for the thorough review of our
manuscript.
Additional files
Additional file 1: Figure S1. Expression of C-terminal D1 polypeptides
in WT mice. Figure S2: Expression of activated-caspase-3 in
hematopoietic lineage cells from Ccnd1Δ1–3 mice. Figure S3: Expression
of Bcl-2 in hematopoietic lineage cells from Ccnd1Δ1–3 mice. Figure S4:
Efficiency and specificity of D1 RNA interference. Figure S5: The Target-
ing vector used to generate Vav1-Cre+/−Ccnd14-5flox+/+ mice. Figure S6:
Characterization of Vav1-Cre+/−Ccnd14-5flox+/+ mice. (PDF 1744 kb)
Additional file 2: Note 1: No alterations in cell death in Ccnd1D1‑3 mice.
Note 2: Strategies that could be used to demonstrate that the truncated D1
4–5 molecule has a role in hematopoiesis and in the expression of D2 and
D3. Note 3: The breeding of Vav1-Cre+/−Ccnd14-5flox+/+ mice generated even
less viable progeny than Ccnd1Δ1–3 breeding. (DOC 25 kb)
Additional file 3: Chaves-Ferreira et al, Additional Materials and
Methods. (DOC 31 kb)
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BM: bone marrow; BrdU: Bromodeoxyuridine (5-bromo-2′-deoxyuridine);
Ccnd1Δ1-3: deletion of exons 1–3 in cyclin D1 gene (Ccnd1); CDK: cyclin
dependent kinases; CLP: common lymphocyte progenitors (Lineage−IL-7R+
Sca-1+CD117+); EGFP: enhanced green fluorescent protein reporter;
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expression of CD24 and CD117; LSK: hematopoietic stem cells (Lineage−
Sca-1+CD117+); mAb: monoclonal antibody; OP-9: murine bone marrow
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